Materias dentro de su búsqueda.
Mostrando 1,281 - 1,300 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 2.80s Limitar resultados
  1. 1281
    “…Pancreatic cancer is one of the cancers with the poorest prognosis, with a 5‐year survival rate of approximately 5–10%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neurotensin receptor 1 signaling promotes pancreatic cancer progression
  2. 1282
    “…Compelling evidence suggests that phosphoprotein phosphatases (PPPs) are involved in a large spectrum of physiological and pathological processes, but little is known about their roles in pancreatic cancer. We investigated the expression level, prognostic value, and potential function of PPPs with data from Oncomine, GEPIA, THPA, and TCGA databases and an independent cohort of patients with pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The role of phosphoprotein phosphatases catalytic subunit genes in pancreatic cancer
  3. 1283
    por Zhou, Wentao, Wang, Dansong, Lou, Wenhui
    Publicado 2020
    “…Pancreatic cancer with synchronous liver metastasis has an extremely poor prognosis, and surgery is not recommended for such patients by the current guidelines. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis
  4. 1284
    “…SIMPLE SUMMARY: For borderline pancreatic cancer, upfront surgery was standard in the past, and the usefulness of neoadjuvant treatment has been reported in recent years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
  5. 1285
    “…Besides, the pharmacological inhibition of EGFR suppressed the initiation of pancreatic cancer and the activation of HSF1 in vivo. Indeed, we demonstrated that the EGFR activation that mediated pancreatic cancer tumorigenesis was partly HSF1-dependent in vitro. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
  6. 1286
    “…Pancreatic cancer is one of the most aggressive malignancies with limited treatment options thus resulting in high morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer
  7. 1287
    “…This review summarises the recent evidence on preoperative therapeutic strategies in pancreatic cancer and discusses the rationale for an imminent need for a personalised therapeutic approach in non-metastatic disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
  8. 1288
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Arginine metabolism: a potential target in pancreatic cancer therapy
  9. 1289
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer
  10. 1290
    por Kato, Shunsuke
    Publicado 2021
    “…However, the improvements in the prognosis of pancreatic cancer and biliary tract cancer is delayed compared to other carcinomas, and the 5-year survival rates of distal-stage disease are approximately 10 and 20%, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer
  11. 1291
    “…SIMPLE SUMMARY: Pancreatic cancer has a poor prognosis, which is largely due to resistance to treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
  12. 1292
    “…The role of ERAD inhibition in enhancing the therapeutic efficacy of FTS was further investigated in pancreatic cancer cells using pharmaceutical and genetic approaches. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
  13. 1293
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Choledocho-duodenal Fistula Formation Caused by the Progression of Pancreatic Cancer
  14. 1294
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer
  15. 1295
    “…Conclusions: Malignant obstruction secondary to pancreatic cancer is amenable by ERCP. However, choosing the right stents still varies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biliary Stenting for Malignant Biliary Obstruction Secondary to Pancreatic Cancer
  16. 1296
    “…These findings suggest that pathogenic ATM alterations may be prognostic for improved outcomes in patients with pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations
  17. 1297
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Case of Recalcitrant Erythema Nodosum Associated with Pancreatic Cancer
  18. 1298
    “…The aim of this review was to summarize knowledge about IL-4 and IL-13 and their receptors in pancreatic cancer in order understand the implication of IL-4 and IL-13 and their receptors for pancreatic tumorigenesis and progression and for developing possible new diagnostic and therapeutic targets.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
  19. 1299
    “…Pancreatic cancer is the most lethal solid malignancy, and the number of patients with pancreatic cancer is increasing. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Endoscopic Ultrasound-Guided Sampling for Personalized Pancreatic Cancer Treatment
  20. 1300
    “…SIMPLE SUMMARY: Improving outcomes in pancreatic cancer is achievable through the accumulation of marginal gains. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Achieving ‘Marginal Gains’ to Optimise Outcomes in Resectable Pancreatic Cancer
Herramientas de búsqueda: RSS